CVS
CVS Health Corporation
CVS Health Corporation insider trading
CVS Health Corporation files with the SEC as a Retail-Drug Stores and Proprietary Stores company headquartered in Woonsocket, RI. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent CVS insider transactions
2 insiders traded CVS on the open market between May 08, 2026 and May 21, 2026 — 9 sales worth $359M.
- Bought
- —
- Sold
- $359M
- Net
- −$359M
- Insiders
- 2
none on a 10b5-1 plan
Robbins Larry
Director
−$34.6M
May 21, 2026
370,462 sh · $93.45
Robbins Larry
Director
−$35.3M
May 21, 2026
378,000 sh · $93.31
Robbins Larry
Director
−$74.6M
May 20, 2026
797,628 sh · $93.48
Robbins Larry
Director
−$14.5M
May 20, 2026
152,691 sh · $94.81
Robbins Larry
Director
−$6.4M
May 20, 2026
66,881 sh · $95.67
Robbins Larry
Director
−$77K
May 20, 2026
800 sh · $96.28
Robbins Larry
Director
−$187.3M
May 19, 2026
1,983,387 sh · $94.45
Robbins Larry
Director
−$14.4K
May 19, 2026
151 sh · $95.18
Mandadi Tilak
EVP, Chief Exp & Tech Officer
−$6.2M
May 08, 2026
69,551 sh · $89.58
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| May 21, 2026 | Robbins LarryDirector | 370,462 | $93.45 | −$34.6M |
| May 21, 2026 | Robbins LarryDirector | 378,000 | $93.31 | −$35.3M |
| May 20, 2026 | Robbins LarryDirector | 797,628 | $93.48 | −$74.6M |
| May 20, 2026 | Robbins LarryDirector | 152,691 | $94.81 | −$14.5M |
| May 20, 2026 | Robbins LarryDirector | 66,881 | $95.67 | −$6.4M |
| May 20, 2026 | Robbins LarryDirector | 800 | $96.28 | −$77K |
| May 19, 2026 | Robbins LarryDirector | 1,983,387 | $94.45 | −$187.3M |
| May 19, 2026 | Robbins LarryDirector | 151 | $95.18 | −$14.4K |
| May 08, 2026 | Mandadi TilakEVP, Chief Exp & Tech Officer | 69,551 | $89.58 | −$6.2M |
SEC Form 4 data, Q3 2024 to Q2 2026
CVS insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 8 insiders traded CVS on the open market: 6 purchases worth $2.1M and 16 sales worth $578.4M. In the last four quarters alone: 0 purchases and 9 sales ($324.2M), by 3 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | — | −$323.7M8 sales | |
| Q1 2026 | — | — | |
| Q4 2025 | — | — | |
| Q3 2025 | — | −$532.7K1 sale | |
| Q2 2025 | +$100K1 buy | −$253.7M6 sales | |
| Q1 2025 | +$2M2 buys | −$498.5K1 sale | |
| Q4 2024 | +$2.6K2 buys | — | |
| Q3 2024 | +$2K1 buy | — |
- Largest purchase
- +$2M of CVS by Mahoney Michael F (Director) on Feb 18, 2025.
- Largest sale
- −$187.3M of CVS by Robbins Larry (Director) on May 19, 2026.
Open-market transactions through Jun 30, 2026most recent first
Robbins Larry
Director
−$34.6M
May 21, 2026
370,462 sh · $93.45
Robbins Larry
Director
−$74.6M
May 20, 2026
797,628 sh · $93.48
Robbins Larry
Director
−$14.5M
May 20, 2026
152,691 sh · $94.81
Robbins Larry
Director
−$6.4M
May 20, 2026
66,881 sh · $95.67
Robbins Larry
Director
−$77K
May 20, 2026
800 sh · $96.28
Robbins Larry
Director
−$187.3M
May 19, 2026
1,983,387 sh · $94.45
Finucane Anne A.
Director
−$532.7K
Aug 20, 2025
7,500 sh · $71.02
Sansone Guy P
Director
+$100K
Jun 05, 2025
1,570 sh · $63.70
Robbins Larry
Director
−$10M
May 06, 2025
150,000 sh · $66.67
Robbins Larry
Director
−$82.7M
May 05, 2025
1,226,933 sh · $67.37
Robbins Larry
Director
−$6.6M
May 05, 2025
96,999 sh · $67.99
Robbins Larry
Director
−$113.2M
May 02, 2025
1,679,736 sh · $67.39
Robbins Larry
Director
−$26M
May 02, 2025
373,776 sh · $69.66
Robbins Larry
Director
−$15.2M
May 02, 2025
222,556 sh · $68.38
Clark James David
SVP, Cont & Chief Acct Officer
−$498.5K
Mar 05, 2025
7,513 sh · $66.35
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| May 21, 2026 | Robbins LarryDirector | 370,462 | $93.45 | −$34.6M |
| May 20, 2026 | Robbins LarryDirector | 797,628 | $93.48 | −$74.6M |
| May 20, 2026 | Robbins LarryDirector | 152,691 | $94.81 | −$14.5M |
| May 20, 2026 | Robbins LarryDirector | 66,881 | $95.67 | −$6.4M |
| May 20, 2026 | Robbins LarryDirector | 800 | $96.28 | −$77K |
| May 19, 2026 | Robbins LarryDirector | 1,983,387 | $94.45 | −$187.3M |
| Aug 20, 2025 | Finucane Anne A.Director | 7,500 | $71.02 | −$532.7K |
| Jun 05, 2025 | Sansone Guy PDirector | 1,570 | $63.70 | +$100K |
| May 06, 2025 | Robbins LarryDirector | 150,000 | $66.67 | −$10M |
| May 05, 2025 | Robbins LarryDirector | 1,226,933 | $67.37 | −$82.7M |
| May 05, 2025 | Robbins LarryDirector | 96,999 | $67.99 | −$6.6M |
| May 02, 2025 | Robbins LarryDirector | 1,679,736 | $67.39 | −$113.2M |
| May 02, 2025 | Robbins LarryDirector | 373,776 | $69.66 | −$26M |
| May 02, 2025 | Robbins LarryDirector | 222,556 | $68.38 | −$15.2M |
| Mar 05, 2025 | Clark James DavidSVP, Cont & Chief Acct Officer | 7,513 | $66.35 | −$498.5K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
CVS Health Corporation company record
- SEC industry classification
- Retail-Drug Stores and Proprietary Stores
- Headquarters
- Woonsocket, RI
- Incorporated in
- DE
- Listed on
- NYSE
- SEC Central Index Key
- 0000064803
- Previously filed as
- CVS CAREMARK CORP
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought CVS
What the stock actually did in the 90 days following each open-market purchase
Don't check CVS — let it ping you
Get told the moment an insider moves on CVS
Pro watches CVS Health Corporation for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add CVS to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read CVS insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are CVS insiders buying or selling?
- Between May 08, 2026 and May 21, 2026, 2 CVS Health Corporation insiders made no open-market purchases and 9 sales worth $359M, a net sale of $359M.
- How much CVS stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 8 CVS Health Corporation insiders made 6 open-market purchases worth $2.1M and 16 sales worth $578.4M. In the four quarters to Jun 30, 2026: no purchases and 9 sales ($324.2M). The largest purchase was Mahoney Michael F buying $2M on Feb 18, 2025. The largest sale was Robbins Larry selling $187.3M on May 19, 2026.
- What was the largest recent CVS insider trade?
- Robbins Larry (Director) sold $187.3M of CVS stock on May 19, 2026 at about $94.45 a share.
- When did an insider last buy CVS shares?
- No open-market purchase by a CVS Health Corporation insider appears in the filings from May 08, 2026 to May 21, 2026 — every recorded open-market transaction in that period was a sale. Before that, the most recent purchase in SEC's data was Sansone Guy P buying $100K on Jun 05, 2025.
- Where does CVS insider trading data come from?
- From the Form 4 filings CVS Health Corporation's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.